@article{ref1,
title="Pharmacotherapy as major risk factor of falls - analysis of 12 months experience in hospitals in South Bohemia",
journal="J Appl Biomed",
year="2019",
author="Malý, Josef and Doseděl, Martin and Vosátka, Jan and Mala-Ladova, Katerina and Kubena, Ales Antonin and Brabcová, Iva and Hajduchová, Hana and Bártlová, Sylva and Tóthová, Valérie and Vlček, Jiří",
volume="17",
number="1",
pages="60-60",
abstract="This study aimed to analyze the effect of fall risk-increasing drugs (FRIDs) and drug-related factors relative to falls through clinical pharmacy service in hospitalized patients, focusing on the relevance of clinical pharmacist evaluation in the context of physician assessment. A prospective study of inpatient falls was conducted in 2017 retrieving data from 4 hospitals in South Bohemia, Czech Republic. An online database was developed to collect patient and fall-related data, and fall evaluation records. Healthcare professionals classified the overall effect of drugs on falls using Likert scale. Univariate and multivariate correlations were performed with a significance level of p < 0.05. Out of the total 280 falls (mean age of patients 77.0 years), a mean of 2.8 diagnoses with fall-related risk, 8.8 drugs, and 4.1 FRIDs per fall were identified. Incidence of falls decreased quarterly (p < 0.001). Use of FRIDs were positively associated with increasing age (p = 0.007). Clinical pharmacists were more likely to identify pharmacotherapy as the relevant fall-related risk, compared to physicians evaluation (p < 0.001). An increasing total number of prescribed drugs as well as higher number of FRIDs increased the suspicion in both professionals in the context of drug-related causes of falls.<p /> <p>Language: en</p>",
language="en",
issn="1214-0287",
doi="10.32725/jab.2019.001",
url="http://dx.doi.org/10.32725/jab.2019.001"
}